Haloprogin (2,4,5-trichlorophenyl-'y-iodopropargyl ether; Fig. 1 ) was synthesized by Seki et al. (7) as part of a series of new acetylenic compounds closely related to capillin and lenamycin.
These investigators found certain y-iodopropargyl aryl ethers to possess strong in vitro antimicrobial activity. Preliminary data on the antifungal properties of haloprogin, originally identified as M-1028, were reported by Seki and associates in 1964 (8) .
This communication confirms the antimicrobial properties of haloprogin previously reported by Seki et al. (8) and extends the evaluation to include a wider spectrum of dermatophytes and other microorganisms. In addition, haloprogin (Halotex, Mead Johnson Laboratories) was compared with tolnaftate both in vitro and in animals treated with steroid to prevent spontaneous remission of the trichophyton infections (2 In vitro antifngal tests. The in vitro fungistatic concentrations were determined by a serial dilution method using Sabouraud's liquid medium (BBL) (1, 3) . The concentration of drugs tested ranged from 0.19 to 100 jg/ml. All tubes were inoculated with approximately 105 viable macrospores obtained by washing the surface of a 14-day slant culture of the test dermatophyte with Sabouraud's liquid medium and diluting to the desired concentration. The inoculated assay tubes were incubated at room temperature (28 C) for 7 days and examined for visible growth. The minimal inhibitory concentration (MIC) was the lowest level of drug that completely prevented growth of the dermatophyte.
Beginning with the lowest concentration of drug that inhibited growth in the MIC test, streak plates were made on Sabouraud's dextrose agar from the tubes containing the next five higher drug concentrations. The plates were incubated at 28 C for 7 days and examined for the presence of fungal growth. The lowest concentration of drug that prevented growth upon subculture was considered to be the minimal fungicidal concentration (MFC). In vivo antifungal evaluation with steroid-treated animals. Steroid treatment has been used to prolong experimentally induced dermatophyte infections in guinea pigs (2) . The scarified skin lesions were infected with T. gypsewn var. asteroides as previously described. On the third day after infection, the animals were divided at random into groups of 15 animals, and the antifungal formulations were applied topically twice daily at 10-to 14-hr intervals for 12 consecutive Hairs were plucked from each infected site on all animals immediately before treatment and on the 4th, 8th, and 12th day of treatment. The hairs were cultured on Littman oxgall agar with additions of streptomycin (50 ,g/ml) and cycloheximide (500 ,g/ml). Cultures were considered negative when no fungal colonies developed after 7 days of incubation at 28 C.
In vitro anti-yeast activity. Yeast nitrogen base medium (Difco) supplemented with 1.5% dextrose and adjusted to pH 4.5 was used to determine the MIC. Total assay volumes were 10 ml in 50-ml Erlenmeyer flasks. Cells for the inoculum consisted of suspending the growth from an 18-to 24-hr slant culture in sterile saline solution, centrifuging, washing, and resuspending the cells to a standardized optical density reading (0.085). Two drops of this suspension were used to inoculate each flask. All flasks were incubated at 28 C with rotary agitation 
RESULTS AND DISCUSSION
The MIC values obtained with haloprogin against several clinically important strains of Microsporum and Trichophyton species ranged from 0.0015 to 0.39 ,ug/ml (Tables 1 and 2 ).
Tolnaftate produced a similar level of activity against these dermatophytes. Haloprogin, however, was effective against a wider spectrum of fungi than tolnaftate. Low MIC values were obtained with Allescheria, Alternaria, Aspergillus, Geotrichum, Keritinomyces, Monosporium, Nigrospora, and Penicillium species by using haloprogin, whereas tolnaftate was essentially inactive against these cultures. (Table 3) .
By dosing the infected animals with triamcinolone acetonide, a prolonged dermatophyte infection was maintained. Significant antifungal activity was detected with haloprogin formulations A and F as early as the 4th day of treatment (Table 4) . By the 12th day of treatment, virtually all of the infected sites had negative cultures. In contrast, the untreated infection control animals maintained a high percentage of positive cultures throughout the test period. By day 8, the antifungal activity of tolnaftate approximated that of haloprogin.
The maintenance of the infection by chronic administration of steroid is not without certain undesirable effects. By the 12th day of steroid treatment, increased mortality was noted not only in the groups receiving antifungal treatment, but also in the infection control group (Table 4) . Tonelli reported a progressive increase in mortality after a single subcutaneous injection of triamcinolone acetonide to rats and mice (9, 10) .
Haloprogin demonstrates good in vitro inhibitory activity against different species of yeast and yeastlike fungi. All cultures are very sensitive to haloprogin (MIC values < 1 jig/ml). Considerably higher concentrations of undecylenic acid (10 to 25 ,ug/ml) are required for inhibition of APPL. MICROBIOL. these cultures. Tolnaftate is essentially inactive since no significant inhibition of growth is observed at concentrations from 25 to 100 ,ug/ml (Table 5) .
In addition, haloprogin shows good in vitro inhibitory activity against gram-positive cocci (Staphylococcus and Streptococcus species). Undecylenic acid and tolnaftate are essentially inactive against all of the bacterial cultures tested (Table 6 ).
In summary, haloprogin possesses potent antifungal activity both in vitro and in vivo. Its spectrum of activity also includes yeast, yeastlike fungi, and gram-positive bacteria. Based on its broader spectrum of antimicrobial activity, haloprogin may prove to be a superior topical agent in the treatment of dermatophytic and monilial infections in man.
